explore -WSS

explore

author：explore 2025-09-29 12:30:08 - browse：2

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： WATCH: Why do our ears pop?

focus

Wikipedia

WSS

Flagship Pioneering startup Sonata Therapeutics lays off 21

Researchers tackle phage therapy hurdles for wider adoption

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

As AI regulations shape up, health tech startups beg for clarity

New study raises questions about niacin and heart health

A public health expert passes on football's full body collisions for youths

Wikipedia

explore

knowledge

In age of alternative facts, a scholarly course on calling out crap

How to fix the rural physician shortage in the U.S.

Duchenne breakthrough therapy leaves behind pioneering families

Novo pauses ads for weight loss drug Wegovy amid demand

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

A public health expert passes on football's full body collisions for youths

Wildfire smoke exposes gaps in outdoor worker protections

Secretariat’s lessons for human medicine

How one medical school became remarkably diverse

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

knowledge

Senate panel passes drug pricing bills, but drops one PBM reform

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Millions may soon lose Medicaid when they don't have to

Timeline: Key moments in fight for gay rights

Senate panel passes drug pricing bills, but drops one PBM reform

focus

focus

Wikipedia

knowledge